Resonance Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 11-12-2024
- Paid Up Capital ₹ 2.32 M
as on 11-12-2024
- Company Age 44 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 11-12-2024
- Satisfied Charges ₹ 1.55 Cr
as on 11-12-2024
- Revenue 22.31%
(FY 2023)
- Profit 193.16%
(FY 2023)
- Ebitda 95.40%
(FY 2023)
- Net Worth 20.98%
(FY 2023)
- Total Assets 25.54%
(FY 2023)
About Resonance Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 2.32 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kumbale Subbaswami, Tushar Gore, and Ramya Kumbale serve as directors at the Company.
- CIN/LLPIN
U24110KA1980PTC045343
- Company No.
045343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 1980
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Resonance Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Gore  | Director | 26-Feb-2009 | Current |
| Kumbale Subbaswami | Director | 14-Mar-1985 | Current |
| Ramya Kumbale | Director | 08-Nov-2013 | Current |
Financial Performance of Resonance Laboratories.
Resonance Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.31% increase. The company also saw a substantial improvement in profitability, with a 193.16% increase in profit. The company's net worth Soared by an impressive increase of 20.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Resonance Laboratories?
In 2023, Resonance Laboratories had a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Jun 2023 | ₹1.00 Cr | Open |
Karnataka State Financial Corporation Creation Date: 07 Mar 1998 | ₹5.60 M | Satisfied |
The Karnataka State Financial Corpoation Creation Date: 30 May 1992 | ₹5.33 M | Satisfied |
How Many Employees Work at Resonance Laboratories?
Resonance Laboratories has a workforce of 87 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Resonance Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resonance Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
